Are we on the verge of a vaccine? Let our COVID-19 expert explain if you are coveringNovember 9, 20201 min read
It’s breaking news that is dominating headlines, impacting financial markets and perhaps finally relieving some of the anxiety that has been growing across America since late winter. On Monday, Pfizer announced that early results from its coronavirus vaccine indicate that it is 90 percent effective at preventing COVID-19.
The pharmaceutical giant expects to be applying as soon as this month for emergency use approval from the Food and Drug Administration.
If you are covering this breaking news and need to know about:
- What is the testing process for vaccines?
- How they are developed?
- What is involved in final approval?
- How will it be administered?
- And how quickly will it take to show positive results in our population?
Then let the experts from UConn help with your coverage.
Dr. Paulo Verardi is a virologist who specializes in vaccine research and development. He is an Associate Professor at UConn and a member of the Center of Excellence for Vaccine Research. Dr. Verardi is available to speak with media regarding this emerging development – simply click on his icon now to arrange an interview today.
Paulo Verardi, Ph.D. Associate Professor
Expert on vaccine development & virology (Smallpox, Rinderpest, Zika, coronaviruses, Rift Valley, Powassan, SFTSV, Heartland, & more)